(Q30658080)

English

Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 June 2017

Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data (English)

1 reference

Europe PubMed Central

26 June 2017

cervical intraepithelial neoplasia

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

Hester E. de Melker

4

object named as

Hester E de Melker

1 reference

Europe PubMed Central

26 June 2017

Chris J L M Meijer

5

object named as

Chris J L M Meijer

1 reference

Europe PubMed Central

26 June 2017

author name string

Margaretha A Vink

1

1 reference

Europe PubMed Central

26 June 2017

Johannes A Bogaards

2

1 reference

Europe PubMed Central

26 June 2017

Folkert J van Kemenade

3

1 reference

Europe PubMed Central

26 June 2017

Johannes Berkhof

6

1 reference

Europe PubMed Central

26 June 2017

language of work or name

0 references

publication date

28 July 2013

1 reference

Europe PubMed Central

26 June 2017

American Journal of Epidemiology

1 reference

Europe PubMed Central

26 June 2017

178

1 reference

Europe PubMed Central

26 June 2017

7

1 reference

Europe PubMed Central

26 June 2017

1161-1169

1 reference

Europe PubMed Central

26 June 2017

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Human papillomavirus testing in the prevention of cervical cancer

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

How many cervical cancers are prevented by treatment of screen-detected disease in young women?

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Natural history of cervical neoplasia: consistent results obtained by an identification technique

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Non-progression of cervical intraepithelial neoplasia estimated from population-screening data

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Health and economic implications of HPV vaccination in the United States

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Incorporating frailty in a multi-state model: application to disease natural history modelling of adenoma-carcinoma in the large bowel.

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Process of care failures in invasive cervical cancer: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

The health and economic effects of HPV DNA screening in The Netherlands

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWT077

21 January 2018

Identifiers

10.1093/AJE/KWT077

1 reference

Europe PubMed Central

26 June 2017

1 reference

Europe PubMed Central

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30658080&oldid=2043804423"